
December 8, 2022
Phase I Clinical Trial Using CAR-T for Glioblastoma to Begin at UNC Medical Center
UNC Health is leading the way in glioblastoma treatment with a new clinical trial. The study will evaluate the safety and tolerability of CAR-T immunotherapy in patients with recurrent or progressive glioblastoma.